中国生物工程杂志

［1］ 刘伯宁, 石磊,蒋沁. 环脂肽抗生素的研究进展. 中国抗生素,2007,32(9),520525. Liu B, Shi L, Jiang Q.Chinese Journal of Antibiotics,2007,32(9):520525. 
［2］ Brown E D. Microbiology: Antibiotic stops ‘pingpong’ match. Nature,2006,441(7091):293294. 
［3］ Guay D R. Daptomycin: The first approved lipopeptide antimicrobial. Consult Pharm,2004,19(7):614628. 
［4］Abbott B J, Debono M,Fukuda D S. A21978c cyclic peptides:United States,4524135.1985618.
［5］ Debono M, Barnhart M, Carrell C B， et al. A21978c, a complex of new acidic peptide antibiotics: Isolation, chemistry, and mass spectral structure elucidation. J Antibiot (Tokyo),1987,40(6):761777. 
［6］Eaton T E, Ford L M, Godfrey J, et al. Process for producing the a21978c antibiotics:United States,4800157.1989624. 
［7］Huber F M, Pieper R L,Tietz A J. Process for producing a21978c derivatives:United States,4885243.1989125. 
［8］ Lakey J H,Lea E J. The role of acyl chain character and other determinants on the bilayer activity of a21978c an acidic lipopeptide antibiotic. Biochim Biophys Acta,1986,859(2):219226. 
［9］ Debono M, Abbott B J, Molloy R M， et al. Enzymatic and chemical modifications of lipopeptide antibiotic a21978c: The synthesis and evaluation of daptomycin (ly146032). J Antibiot (Tokyo),1988,41(8):10931105. 
［10］Bernard J A, Debono M,Fukuda D S. Derivatives of a21978c cyclic peptides:United States,4537717.1985827. 
［11］ Boeck L D, Fukuda D S, Abbott B J， et al. Deacylation of a21978c, an acidic lipopeptide antibiotic complex, by actinoplanes utahensis. J Antibiot (Tokyo),1988,41(8):10851092. 
［12］ Eliopoulos G M, Willey S, Reiszner E， et al. Invitro and invivo activity of ly146032 a new cycle lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy,1986,30(4):532535. 
［13］ Huber F M, Pieper R L,Tietz A J. The formation of daptomycin by supplying decanoic acid to streptomyces roseosporus cultures producing the antibiotic complex a21978c. Journal of Biotechnology,1988, 7(4):283192. 
［14］Baker P J, Debono M, Farid K Z， et al. Anhydro and isomera21978c cyclic peptides:United States,5912226,2006418. 
［15］ Kirsch L E, Molloy R M, Debono M， et al. Kinetics of the aspartyl transpeptidation of daptomycin, a novel lipopeptide antibiotic. Pharmaceutical Research,1989,6(5):387393. 
［16］ McHenney M A,Baltz R H. Gene transfer and transposition mutagenesis in streptomyces roseosporus: Mapping of insertions that influence daptomycin or pigment production. Microbiology,1996,142 ( Pt 9)23632373. 
［17］ McHenney M A, Hosted T J, Dehoff B S， et al. Molecular cloning and physical mapping of the daptomycin gene cluster from streptomyces roseosporus. J Bacteriol,1998,180(1):143151. 
［18］ Baltz R H. Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol,2006,24(12):15331540. 
［19］ Grunewald J,Marahiel M A. Chemoenzymatic and templatedirected synthesis of bioactive macrocyclic peptides. Microbiol Mol Biol Rev,2006,70(1):121146. 
［20］ Miao V, CoeffetLegal M F, Brian P， et al. Daptomycin biosynthesis in streptomyces roseosporus: Cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology,2005,151(Pt 5):15071523. 
［21］ Julia P, Xiang L, Whiting A， et al. Heterologous production of daptomycin in streptomyces lividans. Journal of Industrial Microbiology & Biotechnology,2006,33(2):121128. 
［22］ Miao V, Brost R, Chapple J， et al. The lipopeptide antibiotic a54145 biosynthetic gene cluster from streptomyces fradiae. J Ind Microbiol Biotechnol,2006,33(2):129140.
 ［23］ Hojati Z, Milne C, Harvey B， et al. Structure, biosynthetic origin, and engineered biosynthesis of calciumdependent antibiotics from streptomyces coelicolor. Chem Biol,2002,9(11):11751187. 
［24］ Nguyen K T, Ritz D, Gu J Q， et al. Combinatorial biosynthesis of novel antibiotics related to daptomycin. Proceedings of the National Academy of Sciences of the United States of America,2006,103(46):1746217467. 
［25］ Baltz R H, Brian P, Miao V， et al. Combinatorial biosynthesis of lipopeptide antibiotics in streptomyces roseosporus. Journal of Industrial Microbiology & Biotechnology,2006,33(2):6674. 
［26］ Miao V, CoeffetLe Gal M F, Nguyen K， et al. Genetic engineering in streptomyces roseosporus to produce hybrid lipopeptide antibiotics. Chem Biol,2006,13(3):269276. 
［27］ Nguyen K T, Kau D, Gu J Q， et al. A glutamic acid 3methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in streptomyces roseosporus. Molecular Microbiology,2006,61(5):12941307. 
［28］ 范晶华.达托霉素高产菌株选育与发酵条件优化.天津：天津大学，化工学院，2007. Fan J H，Study on the Breeding of High Daptomycin Producing Strains and Fermentation Conditions Optimization Tianjin ：Tianjin University,School of Chemical Engineering and Technology,2007. 
［29］ 王建平.达托霉素菌种诱变与发酵条件研究.天津：天津大学,化工学院，2007. Wang J P，Study on Screening of daptomycin Producing Strains and fermentation Conditions.Tianjin ：Tianjin University,School of Chemical Engineering and Technology,2007. 
［30］ Kim H B, Smith C P, Micklefield J， et al. Metabolic flux analysis for calcium dependent antibiotic (cda) production in streptomyces coelicolor. Metab Eng,2004,6(4):313325. 
［31］ Baltz R H, Miao V,Wrigley S K. Natural products to drugs: Daptomycin and related lipopeptide antibiotics. Nat Prod Rep,2005,22(6):717741.